11:04 AM EDT, 10/16/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher late Thursday morning, rising 0.80% to 1,586.74 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies ( DBVT ) and Cellectis ( CLLS ) , which climbed 11% and 8.8%, respectively. They were followed by pharmaceutical company Sanofi ( SNY ) and telecommunications company Nokia ( NOK ) , which advanced 2.4% and 2.3%, respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS ( EDAP ) and biotech firm Evaxion ( EVAX ) , which fell 5% and 2.5%, respectively. They were followed by semiconductor company Sequans Communications ( SQNS ) and biopharmaceutical company Genfit ( GNFT ) , which lost 1.6% and 0.7%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Biodexa Pharmaceuticals ( BDRX ) , which surged 27% and 6.7%, respectively. They were followed by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and alcoholic beverage company Diageo ( DEO ) , which was up 5.2% and 3.2%, respectively.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech ( TRIB ) and software company Endava ( DAVA ) , which dropped 4.1% and 2%, respectively. They were followed by insurance company Prudential (PUK) and biotech firm Autolus Therapeutics ( AUTL ) , which were down 1% and 0.6%, respectively.